GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Searle Co Ltd (KAR:SEARL) » Definitions » Other Net Income (Loss)

The Searle Co (KAR:SEARL) Other Net Income (Loss) : ₨-4,003 Mil (TTM As of Mar. 2025)


View and export this data going back to 1993. Start your Free Trial

What is The Searle Co Other Net Income (Loss)?

The Searle Co's Other Net Income (Loss) for the three months ended in Mar. 2025 was ₨-515 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 was ₨-4,003 Mil.

The Searle Co's quarterly Other Net Income (Loss) declined from Sep. 2024 (₨141 Mil) to Dec. 2024 (₨-836 Mil) but then increased from Dec. 2024 (₨-836 Mil) to Mar. 2025 (₨-515 Mil).

The Searle Co's annual Other Net Income (Loss) increased from Jun. 2022 (₨-0 Mil) to Jun. 2023 (₨449 Mil) but then declined from Jun. 2023 (₨449 Mil) to Jun. 2024 (₨-3,389 Mil).


The Searle Co Other Net Income (Loss) Historical Data

The historical data trend for The Searle Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Searle Co Other Net Income (Loss) Chart

The Searle Co Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 448.67 -3,389.29

The Searle Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -304.32 -2,792.42 140.97 -836.37 -515.36

The Searle Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨-4,003 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Searle Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of The Searle Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


The Searle Co Business Description

Traded in Other Exchanges
N/A
Address
Tipu Sultan Road, Plot No. 1, One IBL Centre, 2nd Floor, Block 7 and 8, D.M.C.H.S, Off Shahra-e-Faisal, Karachi, SD, PAK, 75530
The Searle Co Ltd is a pharmaceutical company. It is principally engaged in the manufacture of pharmaceutical and other consumer products. The company manufactures pharmaceutical products like Hydryllin, Extor, Nuberol, Forte, Peditral, Selanz SR, Tramal, and other products. Its pharmaceutical product range covers the therapeutic areas of cardiovascular, antibiotics, nutrition, respiratory care, gastroenterology, oncology, hepatology, neurology and psychiatry, probiotics, antibiotics, and nutritional care.

The Searle Co Headlines

No Headlines